Skip to content

Clinical trials

Phase 1/2 Melanoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Clear all

433 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
200210
20038
20049
200513
200614
200710
20088
200911
201017
20118
201212
201310
201420
201523
201620
201721
201831
201920
202025
202124
202222
202322
202416
202519
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed168
Terminated88
Recruiting74
Unknown status36
Active, not recruiting30
Withdrawn25
Not yet recruiting8
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
M.D. Anderson Cancer Center15
Craig L Slingluff, Jr7
Merck Sharp & Dohme LLC7
Novartis Pharmaceuticals7
Incyte Corporation6
Radboud University Medical Center6
H. Lee Moffitt Cancer Center and Research Institute5
Incyte Biosciences International Sàrl5
Ludwig Institute for Cancer Research5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma433
Carcinoma, Non-Small-Cell Lung91
Neoplasm Metastasis63
Neoplasms55
Carcinoma, Renal Cell52
Squamous Cell Carcinoma of Head and Neck42
Ovarian Neoplasms41
Colorectal Neoplasms39
Stomach Neoplasms36
Breast Neoplasms34

Trials

Showing 51 to 75 of 433. Each trial links to its page on Pharma Observatory.

333 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.